MetaCap

Fennec Pharmaceuticals Insider Trades

NASDAQ: FENCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.71+0.08 (+0.75%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
9 · $1.73M
Shares bought / sold
0 / 161.02K
Net activity
Net selling $1.7 million

Fennec Pharmaceuticals insider activity

Over the last 12 months, Fennec Pharmaceuticals insiders reported 47 transactions on SEC Form 4: 0 open-market purchases and 9 sales. Insiders bought $0 and sold $1.7 million worth of stock, for net insider selling of $1.7 million. The largest seller was Andrade Robert, with $883,500 in reported sales.

The most recent filing shows Sayad Pierre Sargis (Chief Medical Officer) reporting a transaction in 168 shares on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put FENC's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

FENC insider transactions

Fennec Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Sep 30, 2026Hackman Jeffrey S.Chief Executive OfficerAward1,159—Form 4
Sep 30, 2026Evans Terry LChief Commercial OfficerAward168—Form 4
Sep 30, 2026Andrade RobertCHIEF FINANCIAL OFFICERAward1,703—Form 4
Sep 30, 2026Cioffi Christiana MarieChief Strategy OfficerAward156—Form 4
Sep 30, 2026Sayad Pierre SargisChief Medical OfficerAward168—Form 4
Sep 15, 2026Brughera Marco MariaDirectorSale15,545$159.96KForm 4
Sep 15, 2026Brughera Marco MariaDirectorOption exercise15,545$32.80KForm 4
Sep 1, 2026Raykov RostyFormer DirectorSale10,000$121.10KForm 4
Aug 31, 2026Hackman Jeffrey S.Chief Executive OfficerAward1,159—Form 4
Aug 31, 2026Andrade RobertCHIEF FINANCIAL OFFICERAward1,703—Form 4
Aug 31, 2026Cioffi Christiana MarieChief Strategy OfficerAward156—Form 4
Aug 31, 2026Evans Terry LChief Commercial OfficerAward168—Form 4
Aug 31, 2026Sayad Pierre SargisChief Medical OfficerSale12,000$146.16KForm 4
Aug 31, 2026Sayad Pierre SargisChief Medical OfficerAward168—Form 4
Aug 31, 2026Raykov RostyFormer DirectorAward2,778—Form 4
Aug 28, 2026Andrade RobertCHIEF FINANCIAL OFFICEROption exercise21,928$111.83KForm 4
Aug 27, 2026Andrade RobertCHIEF FINANCIAL OFFICERSale75,000$883.50KForm 4
Aug 3, 2026Raykov RostyFormer DirectorSale10,000$95.80KForm 4
Jul 31, 2026Andrade RobertCHIEF FINANCIAL OFFICERAward1,703—Form 4
Jul 31, 2026Raykov RostyFormer DirectorAward2,778—Form 4
Jul 31, 2026Cioffi Christiana MarieChief Strategy OfficerAward156—Form 4
Jul 31, 2026Evans Terry LChief Commercial OfficerAward168—Form 4
Jul 31, 2026Hackman Jeffrey S.Chief Executive OfficerAward1,159—Form 4
Jul 31, 2026Sayad Pierre SargisChief Medical OfficerAward168—Form 4
Jul 1, 2026Raykov RostyFormer DirectorSale9,599$99.93KForm 4
Jul 1, 2026Raykov RostyFormer DirectorOption exercise15,597$38.21KForm 4
Jul 1, 2026Raykov RostyFormer DirectorAward2,778—Form 4
Jun 30, 2026Cioffi Christiana MarieChief Strategy OfficerAward156—Form 4
Jun 30, 2026Andrade RobertCHIEF FINANCIAL OFFICERAward1,703—Form 4
Jun 30, 2026Hackman Jeffrey S.Chief Executive OfficerAward1,159—Form 4
Jun 30, 2026Evans Terry LChief Commercial OfficerAward168—Form 4
Jun 30, 2026Sayad Pierre SargisChief Medical OfficerAward168—Form 4
Jun 1, 2026Raykov RostyDirectorSale9,747$93.77KForm 4
Jun 1, 2026Raykov RostyDirectorOption exercise15,597$38.21KForm 4
May 31, 2026Evans Terry LChief Commercial OfficerAward168—Form 4
May 31, 2026Hackman Jeffrey S.Chief Executive OfficerAward1,159—Form 4
May 31, 2026Sayad Pierre SargisChief Medical OfficerAward168—Form 4
May 31, 2026Andrade RobertCHIEF FINANCIAL OFFICERAward1,703—Form 4
May 31, 2026Cioffi Christiana MarieChief Strategy OfficerAward156—Form 4
May 31, 2026Raykov RostyDirectorAward2,778—Form 4
May 11, 2026RALLIS CHRIS ADirectorSale8,346$58.76KForm 4
May 11, 2026RALLIS CHRIS ADirectorOption exercise14,344$35.00KForm 4
May 1, 2026Raykov RostyDirectorSale10,781$69.75KForm 4
May 1, 2026Raykov RostyDirectorOption exercise15,598$38.22KForm 4
Apr 30, 2026Cioffi Christiana MarieChief Strategy OfficerOption exercise155—Form 4
Apr 30, 2026Evans Terry LChief Commercial OfficerOption exercise168—Form 4
Apr 30, 2026Raykov RostyDirectorOption exercise2,778—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related